We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $579M
1-Year Est. Return 94.36%
This Fund
S&P 500
This Quarter Est. Return
-31.66%
1 Year Est. Return
+94.36%
3 Year Est. Return
+196.81%
5 Year Est. Return
+210.19%
10 Year Est. Return
AUM
$383M
AUM Growth
-$249M
Cap. Flow
+$27.4M
Cap. Flow %
7.16%
Top 10 Hldgs %
65.77%
Holding
65
New
21
Increased
7
Reduced
6
Closed
8

Sector Composition

1 Healthcare 17.15%
2 Industrials 17.12%
3 Materials 8.71%
4 Energy 8.61%
5 Consumer Discretionary 8.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JPM icon
26
JPMorgan Chase
JPM
$913B
$2.7M 0.71%
30,000
MRNS
27
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$2.54M 0.66%
+312,500
New +$2.71M
IHC
28
DELISTED
Independence Holding Company
IHC
$2.43M 0.63%
94,947
-14,476
-13% -$541K
CUE icon
29
Cue Biopharma
CUE
$131M
$2.34M 0.61%
5,500
CDNA icon
30
CareDx
CDNA
$2.05B
$2.18M 0.57%
100,000
PYPL icon
31
PayPal
PYPL
$50.2B
$2.15M 0.56%
+22,500
New +$2.48M
DUOT icon
32
Duos Technologies
DUOT
$264M
$2.15M 0.56%
+453,616
New +$2.37M
AXP icon
33
American Express
AXP
$243B
$2.14M 0.56%
25,000
-53,106
-68% -$6.18M
BLFS icon
34
BioLife Solutions
BLFS
$1.42B
$2.01M 0.53%
+211,942
New +$2.91M
RIBT
35
DELISTED
RiceBran Technologies
RIBT
$2M 0.52%
200,333
EPD icon
36
Enterprise Products Partners
EPD
$82.9B
$1.81M 0.47%
126,301
AMP icon
37
Ameriprise Financial
AMP
$47.6B
$1.64M 0.43%
15,993
-5,331
-25% -$790K
DNTH icon
38
Dianthus Therapeutics
DNTH
$5.61B
$1.58M 0.41%
+15,742
New +$2.92M
DISH
39
DELISTED
DISH Network Corp.
DISH
$1.55M 0.41%
+77,500
New +$2.51M
LBTYK icon
40
Liberty Global Class C
LBTYK
$3.42B
$1.09M 0.29%
69,618
GRTS
41
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$984K 0.26%
+169,039
New +$1.42M
ORTX
42
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$943K 0.25%
+12,520
New +$1.44M
RTN
43
DELISTED
Raytheon Company
RTN
$566K 0.15%
+6,000
New +$1.19M
MTB icon
44
M&T Bank
MTB
$36.3B
$545K 0.14%
5,274
-1,758
-25% -$259K
INFI
45
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$419K 0.11%
500,000
LBTYA icon
46
Liberty Global Class A
LBTYA
$3.53B
$380K 0.1%
22,989
XFOR icon
47
X4 Pharmaceuticals
XFOR
$357M
$357K 0.09%
1,191
HYACW
48
DELISTED
Haymaker Acquisition Corp. II Warrant
HYACW
$350K 0.09%
+333,333
New +$510K
TRAK icon
49
ReposiTrak
TRAK
$159M
$315K 0.08%
82,787
-353,658
-81% -$1.7M
LHX icon
50
L3Harris
LHX
$53B
$288K 0.08%
1,600

Similar funds

Bleichroeder LP's Q1 2020 Portfolio in Review

As of Q1 2020, Bleichroeder LP held 65 positions worth $383M, down 39% from $632M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Bleichroeder LP deployed $27.4M of net new capital in Q1 2020, opening 21 new positions and adding to 7 existing holdings. Its largest new stake was Optimum Communications Inc: 603,600 shares worth $13.5M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 28% a quarter earlier, followed by Industrials and Materials.

On the sell side, the largest reduction was American Express, an estimated $6.18M trimmed.

  • Bleichroeder LP's largest Q1 2020 buy was Optimum Communications Inc: 603,600 shares worth $13.5M.
  • Bleichroeder LP added most to Codexis in Q1 2020, an estimated $3.05M increase.
  • Bleichroeder LP's biggest Q1 2020 reduction was American Express, cutting an estimated $6.18M.
  • Bleichroeder LP fully exited Arqule Inc in Q1 2020, selling an estimated $54.9M.
  • Bleichroeder LP's ten largest holdings make up 66% of its $383M portfolio in Q1 2020.
  • Bleichroeder LP opened 21 new positions and closed 8 in Q1 2020.
  • Bleichroeder LP's portfolio value fell 39% quarter-over-quarter to $383M.

Based on Bleichroeder LP's 13F filing for Q1 2020, filed 14 May 2020.